Allogeneic osteoblastic cell therapy (Bone Therapeutics)

N/A

Report date: 2026/01/25 20:00:09

Base Information

Drug NameAllogeneic osteoblastic cell therapy (Bone Therapeutics)
Drug Alias Name人同种异体骨髓来源的成骨细胞ALLOBPRG2001
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Osteogenic cell therapyCell and gene therapy > Cell therapy > Donor > Allogeneic
Mechanisms of ActionCell replacementsOsteogenesis stimulants
TargetsNot applicable
Therapy Area/IndicationsSpinal FusionTibial FracturesFractures, Bone +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumPoland +[8] 
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesBone Therapeutics Sa
China Registration ClassN/A

Develop Information

Active CompaniesLink Health Pharma Co LtdBone Therapeutics SaShenzhen Pregene Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSpinal FusionTibial FracturesFractures, Bone +[4] 

Other Information

ATC CodeN/A
Related LinksN/A